Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02312557
Recruitment Status : Active, not recruiting
First Posted : December 9, 2014
Last Update Posted : May 17, 2021
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Collins Medical Trust
Oregon Health and Science University
Information provided by (Responsible Party):
Julie Graff, OHSU Knight Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 1, 2022
Estimated Study Completion Date : January 1, 2022